Quick Answer
BioNTech SE reported Total Assets of $21.99 billion for the year ending 2025.
- BioNTech SE showed a decrease of -2.4% in Total Assets from 2024 to 2025.
- This data is from BioNTech SE's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), BioNTech SE's Total Assets has grown by 3,267.4%.
- Historical annual values: Fiscal year 2025: $21.99 billion | Fiscal year 2024: $22.53 billion | Fiscal year 2023: $23.01 billion | Fiscal year 2022: $23.28 billion | Fiscal year 2021: $15.83 billion | Fiscal year 2020: $2.32 billion | Fiscal year 2019: $797.65 million | Fiscal year 2018: $652.99 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: